NCT02511119
Unknown
Not Applicable
Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma
Maimónides Biomedical Research Institute of Córdoba0 sites300 target enrollmentJuly 2015
ConditionsMelanoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Melanoma
- Sponsor
- Maimónides Biomedical Research Institute of Córdoba
- Enrollment
- 300
- Primary Endpoint
- Number of participants with Melanoma
- Last Updated
- 10 years ago
Overview
Brief Summary
The aim of this study is to develop a predictive model of risk of developing melanoma. The investigators will used artificial intelligence techniques to analysed images patterns obtained by clinical and dermoscopic pictures. The investigators want to defined a new predictive risk model obtained from genetic information and image analysis of pigmented lesions. This model could help to discriminate more accurately those patients who are most likely to develop melanoma in a high-risk population.
Investigators
Eligibility Criteria
Inclusion Criteria
- •≥18 years of age;
- •Followed up patients in the Pigmented Lesions Unit at Reina Sofia University Hospital with high risk of developing melanoma (First-degree family/personal history of familiar melanoma and/or melanocyticnevi above 50 and/or dysplastic or atypical nevi);
- •All nevi for which there is at least one dermatoscopy registry will be included.
Exclusion Criteria
- •not enough data in the patient clinical history;
- •located lesions on the face, scalp, mucous membrane or on acral área;
- •nodular or metastatic melanoma diagnosis
- •type V or VI of Fitzpatrick phototyping scale
Outcomes
Primary Outcomes
Number of participants with Melanoma
Time Frame: Three years
Similar Trials
Unknown
Not Applicable
Melanoma: Genomic Profiles, Molecular Markers and Therapeutic ImplicationsMelanomaNCT05119829Hellenic Cooperative Oncology Group80
Active, not recruiting
Not Applicable
A Model for Genetic Susceptibility: MelanomaMelanomaSkin CancerNCT00591500Memorial Sloan Kettering Cancer Center4,082
Unknown
Not Applicable
The Identification of Novel Prognostic Markers in MelanomaMalignant MelanomaNCT01002560Royal Marsden NHS Foundation Trust500
Active, not recruiting
Not Applicable
MElanoma Research Lymph Node Prediction Implementation National_001MelanomaNCT04759781SkylineDx1,820
Unknown
Not Applicable
The Role of Genetic Mutations and of Circulating mRNAs in Uveal MelanomaUveal MelanomaNCT05179174University of Catania102